Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid Ethyl Ester SCHEMBL4483715 | 0.95 | TSHR (0.42) | TSHRHPGDHCAR2ALDH1A1TP53 | |
| Acrylic Acid Ethyl Ester SCHEMBL5654267 | 0.95 | TSHR (0.42) | TSHRHPGDHCAR2ALDH1A1TP53 | |
| Acrylic Acid Ethyl Ester SCHEMBL8637472 | 0.89 | TSHR (0.46) | TSHRHPGDHCAR2ALDH1A1TP53 | |
| Acrylic Acid Ethyl Ester SCHEMBL10729431 | 0.87 | TSHR (0.41) | TSHRHPGDHCAR2ALDH1A1TP53 | |
| Acrylic Acid Ethyl Ester SCHEMBL2703768 | 0.86 | TSHR (0.54) | TSHRHPGDHCAR2ALDH1A1TP53 | |
| Acrylic Acid Ethyl Ester SCHEMBL7521917 | 0.86 | TSHR (0.54) | TSHRHPGDHCAR2ALDH1A1TP53 | |
| Acrylic Acid Ethyl Ester SCHEMBL11847163 | 0.85 | TSHR (0.43) | TSHRHPGDHCAR2ALDH1A1TP53 | |
| Acrylic Acid Ethyl Ester SCHEMBL156717 | 0.84 | TSHR (0.48) | TSHRHPGDHCAR2ALDH1A1TP53 | |
| Acrylic Acid Ethyl Ester SCHEMBL9818307 | 0.84 | TSHR (0.48) | TSHRHPGDHCAR2ALDH1A1TP53 | |
| Acrylic Acid Ethyl Ester SCHEMBL9069456 | 0.84 | TSHR (0.48) | TSHRHPGDHCAR2ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025094171-A1 | SUPERHYDROPHOBIC COATING | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-05-08 | — | — | WO | claimed |
| EP-4121017-A1 | EXPANDABLE, MULTI-EXCIPIENT STRUCTURED DOSAGE FORM FOR PROLONGED DRUG RELEASE | Blaesi, Aron H. (CH) | 2023-01-25 | — | — | EP | claimed |
| US-20220304924-A1 | Expandable multi-excipient dosage form | BLAESI, ARON H. (US) | 2022-09-29 | — | — | US | claimed |
| WO-2021188742-A1 | EXPANDABLE, MULTI-EXCIPIENT STRUCTURED DOSAGE FORM FOR PROLONGED DRUG RELEASE | BLAESI ARON H (US) | 2021-09-23 | — | — | WO | claimed |
| WO-2009067684-A1 | MODIFIED RELEASE NIACIN FORMULATIONS | CAPRICORN PHARMA INC. (US) | 2009-05-28 | — | — | WO | claimed |
| US-20090130208-A1 | Modified release niacin formulations | CAPRICORN PHARMA INC. (US) | 2009-05-21 | — | — | US | claimed |
| WO-2025094171-A1 | SUPERHYDROPHOBIC COATING | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-05-08 | — | — | WO | disclosed |
| WO-2024209462-A1 | ANTI-BIOFILM POLYMER COMPOSITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-10-10 | — | — | WO | disclosed |
| CN-117396189-A | Formulation of a multilayer pill comprising melatonin | 闭环医药有限公司 | 2024-01-12 | — | — | CN | disclosed |
| EP-4121017-A1 | EXPANDABLE, MULTI-EXCIPIENT STRUCTURED DOSAGE FORM FOR PROLONGED DRUG RELEASE | Blaesi, Aron H. (CH) | 2023-01-25 | — | — | EP | disclosed |
| US-20220304924-A1 | Expandable multi-excipient dosage form | BLAESI, ARON H. (US) | 2022-09-29 | — | — | US | disclosed |
| US-11357730-B2 | Controlled activation ingestible identifier | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2022-06-14 | — | — | US | disclosed |
| WO-2021188742-A1 | EXPANDABLE, MULTI-EXCIPIENT STRUCTURED DOSAGE FORM FOR PROLONGED DRUG RELEASE | BLAESI ARON H (US) | 2021-09-23 | — | — | WO | disclosed |
| WO-1999007342-A1 | PROLONGED RELEASE ACTIVE AGENT DOSAGE FORM ADAPTED FOR GASTRIC RETENTION | ALZA CORPORATION (US) | 1999-02-18 | — | — | WO | disclosed |
| US-5788987-A | TIME-SPECIFIC CONTROLLED RELEASE DOSAGE FORMULATION | POLI INDUSTRIA CHIMICA SPA (IT) | 1998-08-04 | — | — | US | disclosed |
| WO-1998032426-A1 | TIME-SPECIFIC CONTROLLED RELEASE DOSAGE FORMULATIONS AND METHOD OF PREPARING SAME | POLIN INDUSTRIA CHIMICA S.P.A. (IT) | 1998-07-30 | — | — | WO | disclosed |
| CN-1179102-A | 2-methyl-thieno-benzodiazepine * oral formulations | LILLY CO ELI (US) | 1998-04-15 | — | — | CN | disclosed |
| EP-0810856-A2 | BANDED PROLONGED RELEASE ACTIVE AGENT DOSAGE FORM | ALZA CORPORATION (US) | 1997-12-10 | — | — | EP | disclosed |
| WO-1996025922-A2 | BANDED PROLONGED RELEASE ACTIVE AGENT DOSAGE FORM | ALZA CORPORATION (US) | 1996-08-29 | — | — | WO | disclosed |
| US-4692295-A | USING A LOWER STRETCHING FORCE BY INCLUDING A HIGH MOLECULAR WEIGHT ADDITIVE ADDITION POLYMER | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1987-09-08 | — | — | US | disclosed |